This morning, UBS upgraded shares of Zynga (NASDAQ:ZNGA) from neutral to buy as core operations are beginning to stabilize and cost cutting efforts are taking hold. In the report, UBS set a price target of $6. Shares of Zynga were higher on the news, gaining 3.3% so far.
Jefferies upgraded shares of Pfizer (NYSE:PFE) from hold to buy as management's restructuring efforts are increasing efficiencies. In the report, Jefferies set a $38 price target. Shares of Pfizer were higher by 2.4% on Tuesday.
And Robert Baird upgraded shares of Gilead (NASDAQ:GILD) from neutral to outperform as the company is seeing stronger sales from its product pipeline. In report, Robert Baird set a $103 price target. Shares of Gilead were higher by 3.4% this afternoon.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.